PixoTest POCT COVID-19 Antigen Test Covered in Med-Tech Innovation News


Med-Tech Innovation News talks about how iXensor can bring smartphone technology to aid COVID-19 testing. Bringing the end-to-end digital COVID-19 screening solution PixoTest® POCT COVID-19 Antigen Testing, iXensor is ready to help organizations preventing outbreaks. “PixoTest provides computer analyzed COVID-19 test results, lowering the risks caused by misinterpretation of human eyes. The…

read more

iXensor announces superior clinical accuracy of its fully digitalized PixoTest® POCT COVID-19 Antigen Test and management solution

iXensor, the pioneer of mobile health, is set to launch its end-to-end digital COVID-19 rapid antigen test solution that digitizes the entire user journey from screening, reporting to access control to combat outbreaks. The clinical performance evaluation has demonstrated superior accuracy of the PixoTest® POCT COVID-19 Antigen Test. The test…

read more

PixoHealth Pass covered in Boston Herald

PixoTest COVID-19 Antigen Test result on PixoHealth Pass App

iXensor, the pioneer of mobile health, infuses its corporate DNA of digital savviness into its upcoming product launch in January 2021. The PixoTest® COVID-19 Antigen Test, together with the PixoTest® POCT Analyzer, can yield positive results objectively in as short as 5 minutes through computer-aided analysis, minimizing the chances of misinterpretation by…

read more

iXensor announces its residency at Johnson Innovation’s JLABS @ Shanghai to further develop smartphone-based rapid tests

iXensor joins the Johnson & Johnson Innovation to expand applications of PixoTech technology platform

iXensor announced today that, effective December 1st, it has become a resident of Johnson & Johnson Innovation – JLABS @ Shanghai. This is an important step toward further accelerating its PixoTech platform development and smartphone-based testing applications for new disease areas, leveraging JLABS’ global network and resources.   Johnson Innovation…

read more